Consolidated Statements of Profit or Loss and Other Comprehensive Loss |
12 Months Ended | |||
|---|---|---|---|---|
|
Dec. 31, 2025
USD ($)
$ / shares
shares
|
Dec. 31, 2025
SGD ($)
$ / shares
shares
|
Dec. 31, 2024
SGD ($)
$ / shares
shares
|
Dec. 31, 2023
SGD ($)
$ / shares
shares
|
|
| Profit or loss [abstract] | ||||
| Revenue | $ 252,265 | $ 324,387 | $ 69,501 | |
| Other operating income | 528,592 | 679,716 | 784,061 | 803,904 |
| Other (losses)/gains including fair value changes on financial instruments - net | 109,120 | 140,318 | 297,545 | (492,910) |
| Lab consumables and cord-blood banking expenses | (52,875) | (67,992) | (17,121) | |
| Research expenses | (1,724,469) | (2,217,495) | (1,909,519) | (1,589,693) |
| Depreciation of property, plant and equipment | (153,119) | (196,896) | (109,842) | (101,866) |
| Amortization of intangible assets | (23,252) | (29,900) | (12,557) | (2,187) |
| Employee benefits expenses | (723,667) | (930,564) | (619,327) | (454,143) |
| Finance expenses | (16,258) | (20,906) | (20,313) | (51,282) |
| Other expenses | (1,299,179) | (1,670,613) | (998,054) | (2,213,142) |
| Share of results of associate | (4,970) | (6,391) | 13,765 | (31,198) |
| Loss before income tax | (3,107,812) | (3,996,336) | (2,521,861) | (4,132,517) |
| Income tax expense | (653) | |||
| Loss for the year | (3,107,812) | (3,996,336) | (2,521,861) | (4,133,170) |
| Other comprehensive (loss)/income: | ||||
| Foreign currency translation (loss)/gain | 102,675 | 132,030 | 163,645 | (89,918) |
| Total comprehensive loss for the year | (3,005,137) | (3,864,306) | (2,358,216) | (4,223,088) |
| Loss attributable to: | ||||
| Equity holders of the Company | (3,095,463) | (3,980,457) | (2,516,698) | (4,132,896) |
| Non-controlling interests | (12,349) | (15,879) | (5,163) | (274) |
| Total | (3,107,812) | (3,996,336) | (2,521,861) | (4,133,170) |
| Total comprehensive loss attributable to: | ||||
| Equity holders of the Company | (2,992,788) | (3,848,427) | (2,353,053) | (4,222,814) |
| Non-controlling interests | (12,349) | (15,879) | (5,163) | (274) |
| Total | $ (3,005,137) | $ (3,864,306) | $ (2,358,216) | $ (4,223,088) |
| Loss per share attributable to equity holders of the Company: | ||||
| Basic | (per share) | $ (0.27) | $ (0.34) | $ (0.22) | $ (0.39) |
| Diluted | (per share) | $ (0.27) | $ (0.34) | $ (0.22) | $ (0.39) |
| Weighted average number of ordinary shares used in computing loss per share | ||||
| Basic | 11,647,225 | 11,647,225 | 11,539,834 | 10,630,344 |
| Diluted | 11,647,225 | 11,647,225 | 11,539,834 | 10,630,344 |
| X | ||||||||||
- Definition Amortization of intangible asset. No definition available.
|
| X | ||||||||||
- Definition Private blood banking expenses. No definition available.
|
| X | ||||||||||
- Definition Profit loss on non-controlling interests. No definition available.
|
| X | ||||||||||
- Definition The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of costs associated with financing activities of the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'function of expense' form for its analysis of expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The gains (losses) that the entity does not separately disclose in the same statement or note. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of operating income (expense) that the entity does not separately disclose in the same statement or note. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method; Profit (loss)] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|